Malaria Therapy
Artesunate improves efficacy of sulfadoxine-pyrimethamine treatment
Published in TB and Outbreaks Week, July 5th, 2005
"To assist the Peruvian Ministry of Health in modifying the malaria treatment policy for their north Pacific coastal region," scientists there "conducted an in vivo efficacy trial of sulfadoxine-pyrimethamine (SP) and SP plus artesunate (SP-AS) for the treatment for uncomplicated Plasmodium falciparium infections."
"A total of 197 patients were randomized to therapy with either SP (25 mg/kg of the sulfadoxine component in a single dose on day 0) or a combination of SP plus AS (4 mg/kg on days 0, 1, and 2), and were followed for 28 days for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Mycobacteriology
Decontamination methods affect recovery of mycobacteria from clinical specimens - Neisseria Meningitides Epidemiology
N. meningitides serogroup W135 exceeds 40% in nonepidemic regions of Niger - Q Fever Outbreak
North wind containing aerosolized C. burnetii influenced Q fever outbreak - Tuberculosis
Recent TB transmission associated with health-care work in low incidence setting - Tuberculosis Surveillance
Screening household contacts improves tuberculosis case detection rates - Acinetobacter Baumannii Outbreaks
3rd-gen. cephalosporin therapy risk for VEB-1 ESBL A. baumannii outbreak - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
